Kit Simpson to Europe
This is a "connection" page, showing publications Kit Simpson has written about Europe.
Connection Strength
0.300
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.138
-
Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Value Health. 2000 May-Jun; 3(3):186-201.
Score: 0.042
-
Health economics in HIV disease. A review of the European literature. Pharmacoeconomics. 1999; 15 Suppl 1:1-12.
Score: 0.039
-
Cost effectiveness of antiviral treatment with zalcitabine plus zidovudine for AIDS patients with CD4+ counts less than 300/microliters in 5 European countries. Pharmacoeconomics. 1994 Dec; 6(6):553-62.
Score: 0.029
-
Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis. AIDS Res Hum Retroviruses. 2014 Aug; 30(8):753-68.
Score: 0.028
-
Indices for monitoring hospital outcomes in developed countries. Health Policy. 1992 May; 21(1):1-15.
Score: 0.024